Respiratory specialists have shared tips for ensuring inhalers are used correctly in a bid to reduce the four deaths caused ...
Insmed remains a Strong Buy as ARIKAYCE, TPIP Phase 3 progress and 44% YoY BRINSUPRI growth drive upside. Click here to read ...
A Queen’s-led study analyzes Ontario inhaler prescription rates through the COVID-19 pandemic and finds high-emission devices still dominate despite calls for greener healthcare.
An insulin inhalation powder has been approved by the FDA for pediatric patients with type 1 or type 2 diabetes.
Collaboration underscores interest in inhaled insulin and strengthens bringing innovation and new options to pediatric diabetes careDANBURY, ...
Insmed Incorporated (NASDAQ:INSM) is among the Best Healthcare Stocks. On June 15, Mizuho lowered its price target on Insmed ...
It didn’t take long for Knicks fans to get an early surprise in Game 3 of the NBA Finals against the Spurs. As guard Josh ...
Transpire Bio Inc., an integrated, U.S.-based, clinical-stage biopharmaceutical company, announced today that its Chief ...
The Kathmandu Post on MSN
DDA seizes suspected counterfeit asthma medicine in nationwide crackdown
Kathmandu, June 26 -- In a major crackdown on illicit and counterfeit drugs being sold in Nepal under the name of a leading Indian pharmaceutical company, the Department of Drug Administration has ...
The global long-acting drugs market is growing steadily, expected to be valued at around US$ 7.2 billion in 2026 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results